AI assistant
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2015
Apr 29, 2015
29864_dirs_2015-04-29_802a81ab-206a-4889-949d-cbd2e7681a86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2015-04-27
Reporting Person: Arbuckle Stuart A (EVP\Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-27 | Common Stock | G | 150 | $0.00 | Disposed | 138120 | Direct |
| 2015-04-27 | Common Stock | M | 18312 | $53.74 | Acquired | 156432 | Direct |
| 2015-04-27 | Common Stock | M | 15563 | $45.11 | Acquired | 171995 | Direct |
| 2015-04-27 | Common Stock | M | 17000 | $77.31 | Acquired | 188995 | Direct |
| 2015-04-27 | Common Stock | S | 21480 | $127.49 | Disposed | 167515 | Direct |
| 2015-04-27 | Common Stock | S | 12933 | $128.17 | Disposed | 154582 | Direct |
| 2015-04-27 | Common Stock | S | 1100 | $129.30 | Disposed | 153482 | Direct |
| 2015-04-27 | Common Stock | S | 11321 | $130.33 | Disposed | 142161 | Direct |
| 2015-04-27 | Common Stock | S | 4230 | $131.27 | Disposed | 137931 | Direct |
| 2015-04-27 | Common Stock | S | 6316 | $132.44 | Disposed | 131615 | Direct |
| 2015-04-27 | Common Stock | S | 3400 | $133.34 | Disposed | 128215 | Direct |
| 2015-04-27 | Common Stock | S | 700 | $134.05 | Disposed | 127515 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-04-27 | Stock Option (right to buy) | $53.74 | M | 18312 | Disposed | 2022-09-03 | Common Stock (18312) | Direct |
| 2015-04-27 | Stock Option (right to buy) | $45.11 | M | 15563 | Disposed | 2023-02-04 | Common Stock (15563) | Direct |
| 2015-04-27 | Stock Option (right to buy) | $77.31 | M | 17000 | Disposed | 2024-02-04 | Common Stock (17000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 140 | Indirect |
Footnotes
F1: Represents a gift made to a charitable organization.
F2: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
F3: Open market sales reported on this line occurred at a weighted average price of $127.49 (range $126.88 to $127.87).
F4: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F5: Open market sales reported on this line occurred at a weighted average price of $128.17 (range $127.88 to $128.82).
F6: Open market sales reported on this line occurred at a weighted average price of $129.30 (range $128.93 to $129.90).
F7: Open market sales reported on this line occurred at a weighted average price of $130.33 (range $129.94 to $130.88).
F8: Open market sales reported on this line occurred at a weighted average price of $131.27 (range $130.94 to $131.92).
F9: Open market sales reported on this line occurred at a weighted average price of $132.44 (range $131.94 to $132.91).
F10: Open market sales reported on this line occurred at a weighted average price of $133.34 (range $132.98 to $133.92).
F11: Open market sales reported on this line occurred at a weighted average price of $134.05 (range $133.99 to $134.09).
F12: The option vests in 16 quarterly installments from 09/04/2012.
F13: The option vests in 16 quarterly installments from 02/05/2013.
F14: The option vests in 16 quarterly installments from 02/05/2014.